Accelerated apoptosis in the Timp-3-deficient mammary gland

Journal of Clinical Investigation

Volumn 108, Issue 6, 2001, Pages 831-841

  Fata, J E ^a   Leco, K J ^a   Voura, E B ^a   Yu, H Y E ^a   Waterhouse, P ^a   Murphy, G ^a   Moorehead, R A ^a   Khokha, R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; FIBRONECTIN; GELATINASE A; RECOMBINANT ENZYME; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; ENZYME SYNTHESIS; LACTATION; MAMMARY GLAND; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUCKLING; ZYMOGRAPHY;

ADIPOSE TISSUE; ANIMALS; APOPTOSIS; CULTURE TECHNIQUES; ENZYME ACTIVATION; EPITHELIAL CELLS; FEMALE; FIBRONECTINS; LACTATION; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASE 2; MICE; MICE, KNOCKOUT; PREGNANCY; TISSUE INHIBITOR OF METALLOPROTEINASE-3;

EID: 0034823461     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200113171     Document Type: Article

References (69)

1. Structural cues from the tissue microenviromnent are essential determinants of the human mammary epithelial cell phenotype
2. A cellular striptease act
3. Tissue inhibitors of matrix metalloproteinases in cancer
4. Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions
5. Tissue inhibitor of metalloproteinases-3 (TIMP-3) is an extracellular matrix-associated protein with a distinctive pattern of expression in mouse cells and tissues
6. Human tissue inhibitor of metalloproteinases 3 interacts with both the N -and C-terminal domains of gelatinases A and B. Regulation by polyanions
7. TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix
8. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy
9. Transcriptional inactivation of the tissue inhibitor of metalloproteinase-3 gene by DNA hypermethylation of the 5′-CpG island in human gastric cancer cell lines
10. Specific methylation events contribute to the transcriptional repression of the mouse tissue inhibitor of metalloproteinases-3 gene in neoplastic cells
11. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3
12. Full-length and N-TIMP-3 display equal inhibitory activities toward TNF-alpha convertase
13. ADAM 12-S cleaves IGFBP-3 and IGFBP-S and is inhibited by TIMP-3
14. Timp-3 is a potent inhibitor of aggrecanase 1 (adam-ts4) and aggrecanase 2 (adam-ts5)
15. Tissue inhibitor of metalloproteinases-3 inhibits shedding of L-selectin from leukocytes
16. Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIM P-3-sensitive metalloproteinase
17. Human myeloma cells shed the interleukin-6 receptor: Inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor
18. Shedding of c-Met is regulated by crosstalk between a G-protein coupled receptor and the EGF receptor and is mediated by a TIMP-3 sensitive metalloproteinase
19. Divergent effects of tissue inhibitor of metalloproteinase-1,-2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro TIMP-3 promotes apoptosis
20. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3
21. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion and induces apoptosis in melanoma cells
22. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3
23. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells
24. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3
25. Localization of the death domain of tissue inhibitor of metalloproteinases-3 to the N terminus. Metalloproteinase inhibition is associated with proapoptoric activity
26. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3)
27. Cellular turnover and extracellular matrix remodeling in female reproducrive tissues: Functions of metalloproteinases and their inhibitors
28. Epithelial integrity, cell death and cell loss in mammalian small intestine
29. Oocyte attrition
30. Adipose cell apoptosis: Death in the energy depot
31. Control of milk secretion and apoptosis during mammary involution
32. Programmed cell death during mammary tissue involution induced by weaning, litter removal, and milk stasis
33. Milk accumulation triggers apoptosis of mammary epithelial cells
34. Two distinct phases of apoptosis in mammary gland involution: Protienase-independent and -dependent pathways
35. Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution
36. Stromelysin-1 regulates adipogenesis during mammary gland involution
37. Matrix metalloproteinases and their expression in mammary gland
38. Mammary plasminogen activator: Correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue
39. Enhanced synthesis of geletinase and stromelysin by myoepithelial cells during involution of the rat mammary gland
40. The breast cancer-associated stromelysin-3 gene is expressed during mouse mammary gland apoptosis
41. Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution
42. Proteinases of the mammary gland: Developmental regulation in vivo and vectorial secretion in culture
43. Apoptotic cell death and tissue remodeling during mouse mammary gland involution
44. Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development
45. The osteoclast differentiation factor osteoproregerin-ligand is essential for mammary gland development
46. Participation of two different mesenchymes in the developing mouse mammary gland: Synthesis of basement membrane components by fat pad precursor cells
47. Fibronectin fragments induce MMP activity in mouse mammary epithelial cells: Evidence for a role in mammary tissue remodeling
48. Cellular turnover in the mammary gland is correlated with the systemic levels of progesterone and not 17-beta-estradiol during the estrous cycle
49. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelarinase A and initiates autoproteolyric activation. Regulation by TIMP-2 and TIMP-3
50. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP)
51. Signal transduction through the fibronectin receptor induces collagenase and stromelysin in gene expression
52. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MTI- MMP (MMP-14) to a 45 kDa form
53. Topographical arrangement of basement membrane proteins in lactating rar mammary gland: Comparison of the distribution of type IV collagen, laminin, fibronectin, and Thy-1 at the ulrastructural level
54. Matrix survival signaling: From fibronectin via focal adhesion kinase to c-Jun NH(2)-terminal kinase
55. Extracellular matrix survival signals transduced by focal adhesion kinase suppress p53-mediated apoptosis
56. Mutations in the heparin binding domain of fibronectin in cooperation with the V region induce decreases in pp125(FAK) levels plus proteoglycan-mediated apoprosis via caspases
57. Enhanced synthesis of gelatinase and stromelysin by myoepithelial cells during involution of the rat mammary gland
58. Adamalysins. A family of metzincins including TNF-alpha converting enzyme (TACE)
59. Tumor necrosis factor-alpha: A multi-functional regulator of mammary gland development
60. Lactation stage dependent changes in levels of tumor necrosis factor/cachectin in milk
61. The metalloproteinase matrilysin proteolytically generates active soluble Fas ligand and potentiates epithelial cell apoprosis
62. Roles of Fas and Fas ligand during mammary gland remodeling
63. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix
64. Suppression of apoptosis by basement membrane requires three-dimensional tissue organization and withdrawal from the cell cycle
65. Dysregulation of apoptosis in cancer
66. Transformation-sensitive protein associated with the cell substratum of chicken embryo fibroblasts
67. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1
68. Apoprosis is accompanied by changes in Bcl-2 and Bax expression, induced by loss of attachment and inhibited by specific extracellular matrix proteins in mammary epithelial cells
69. Insulin-like growth factor II signaling in neoplastic proliferation is blocked by transgenic expression of the metalloproteinase inhibitor TIMP-1